The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Erwan Bezard

CNRS UMR 5543

Laboratoire de Physiologie et Physiopathologie de la Signalisation Cellulaire

Université de Bordeaux 2

146 rue Leo Saignat

France

[email]@*.u-bordeaux2.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • CNRS UMR 5543, Laboratoire de Physiologie et Physiopathologie de la Signalisation Cellulaire, Université de Bordeaux 2, 146 rue Leo Saignat, France. 2006
  • CNRS UMR 5543, Victor Segalen Bordeaux 2 University, Bordeaux, France. 2006
  • Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543, Université de Bordeaux II, France. 1997 - 2003
  • Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester, UK. 2001

References

  1. 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease. Bezard, E., Gerlach, I., Moratalla, R., Gross, C.E., Jork, R. Neurobiol. Dis. (2006) [Pubmed]
  2. A call for clinically driven experimental design in assessing neuroprotection in experimental Parkinsonism. Bezard, E. Behav. Pharmacol (2006) [Pubmed]
  3. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Bezard, E., Gross, C.E., Brotchie, J.M. Trends Neurosci. (2003) [Pubmed]
  4. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Bézard, E., Ferry, S., Mach, U., Stark, H., Leriche, L., Boraud, T., Gross, C., Sokoloff, P. Nat. Med. (2003) [Pubmed]
  5. Neuroprotection for Parkinson's disease: a call for clinically driven experimental design. Bezard, E. Lancet. Neurol (2003) [Pubmed]
  6. Sonic hedgehog is a neuromodulator in the adult subthalamic nucleus. Bezard, E., Baufreton, J., Owens, G., Crossman, A.R., Dudek, H., Taupignon, A., Brotchie, J.M. FASEB J. (2003) [Pubmed]
  7. Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease. Bezard, E., Crossman, A.R., Gross, C.E., Brotchie, J.M. FASEB J. (2001) [Pubmed]
  8. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeys. Bezard, E., Ravenscroft, P., Gross, C.E., Crossman, A.R., Brotchie, J.M. Neurobiol. Dis. (2001) [Pubmed]
  9. Pallidal border cells: an anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey. Bezard, E., Boraud, T., Chalon, S., Brotchie, J.M., Guilloteau, D., Gross, C.E. Neuroscience (2001) [Pubmed]
  10. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A.R., Bioulac, B., Brotchie, J.M., Gross, C.E. J. Neurosci. (2001) [Pubmed]
  11. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse. Bezard, E., Jaber, M., Gonon, F., Boireau, A., Bloch, B., Gross, C.E. Eur. J. Neurosci. (2000) [Pubmed]
  12. Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Bezard, E., Dovero, S., Imbert, C., Boraud, T., Gross, C.E. Synapse (2000) [Pubmed]
  13. Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. Bezard, E., Boraud, T., Bioulac, B., Gross, C.E. Eur. J. Neurosci. (1999) [Pubmed]
  14. Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach. Bezard, E., Gross, C.E. Prog. Neurobiol. (1998) [Pubmed]
  15. Kinetics of nigral degeneration in a chronic model of MPTP-treated mice. Bezard, E., Dovero, S., Bioulac, B., Gross, C.E. Neurosci. Lett. (1997) [Pubmed]
  16. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey. Bezard, E., Imbert, C., Deloire, X., Bioulac, B., Gross, C.E. Brain Res. (1997) [Pubmed]
  17. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Bezard, E., Dovero, S., Bioulac, B., Gross, C. Exp. Neurol. (1997) [Pubmed]
 
WikiGenes - Universities